Bariatric surgery outcomes in morbidly obese with the metabolic syndrome at US academic centers.

Department of Surgery, University of Texas Southwestern, 4500 South Lancaster Road (Ste-112), Dallas, TX, 75216, USA.
Obesity Surgery (Impact Factor: 3.1). 04/2008; 18(10):1273-7. DOI: 10.1007/s11695-008-9526-7
Source: PubMed

ABSTRACT The metabolic syndrome is associated with significant cardiovascular morbidity and mortality. We assessed the in-hospital outcomes of bariatric surgery in morbidly obese patients with the metabolic syndrome in comparison to a control group without the metabolic syndrome.
Using ICD-9-CM diagnosis and procedure codes, clinical data for 20,242 patients with and without the metabolic syndrome who underwent bariatric surgery over a 5-year period were obtained from the University HealthSystem Consortium database.
The prevalence of the metabolic syndrome among bariatric surgery patients was 27.4%. Patients with the metabolic syndrome presented significantly higher overall morbidity as compared to morbidly obese patients without the metabolic syndrome (8.6% vs. 5.8%; p < 0.01), and similar mortality (0.04% vs. 0.01%; p = 0.2) after bariatric surgery. Hispanics with the metabolic syndrome had the highest morbidity rates, and men had the uppermost mortality. In-hospital bariatric surgery outcomes were significantly improved among patients who underwent laparoscopic adjustable gastric banding.
The data suggest that the presence of the metabolic syndrome affects inter-ethnic and gender-specific short-term outcomes after bariatric surgery.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Bariatric surgery is expanding worldwide. In a previous study, we found a threefold increase in the annual incidence in Sweden between 1987 and 1996. The aim of the present study was to describe the nationwide practice of bariatric surgery until 2005 and determine the perioperative mortality. All bariatric procedures were identified through linkage to the Swedish Inpatient Registry, kept by the National Board of Health and Welfare. Mortality data were obtained from the Swedish National Death Registry A total of 8,129 bariatric procedures were identified. Seventy-eight percent of the patients were women and the mean age was 40.3 years. Hospital stay averaged 6 days. There was a 27% increase in the number of procedures performed in 2005 compared to 1995. After a decline in the beginning of the century, an increase of 119% is noted from 2001 to 2005. In the beginning of the study period, simple gastric restrictive procedures dominated (79%), but these procedures declined gradually. Gastric bypass has had the opposite development and reached 79% of all performed bariatric procedures in 2005. Laparoscopy has been introduced under the study period and in 2005, 42% of all gastric bypasses were performed by laparoscopy. The 30-day mortality was 0.16%. In spite of the shift to more complex procedures, the operative mortality was low.
    Obesity Surgery 11/2008; 19(12):1697-701. · 3.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic syndrome (MetS) complicating obesity is endemic in the United States. Bariatric Outcomes Longitudinal Database, the national database for the American Society for Metabolic and Bariatric Surgery Bariatric Surgery Center of Excellence Program, was queried to identify patients undergoing bariatric surgery from June 2007 through November 2010. MetS was defined as the presence of hypertension, diabetes, and dyslipidemia at presentation for bariatric surgery. Ninety-day and 1-year outcomes were assessed to determine early outcomes in bariatric surgery patients with MetS. Among 186,576 research-consented patients, 23,106 (12%) were diagnosed with MetS. Patients with MetS were more likely to be male (35% vs 20%; p < 0.0001), older (mean age 54 vs 44 years; p < 0.0001), and Caucasian (81% vs 74%; p < 0.0001). Of the 23,106 MetS patients, more underwent gastric bypass (RYGB) (62%) compared with gastric banding (32%), sleeve gastrectomy (4.5%), and biliopancreactic diversion with duodenal switch (BPD/DS)(1.5%). MetS patients had an increase in serious complications (2.4% vs 1.0%; p < 0.0001), readmissions (6.2% vs 4.7%; p < 0.0001), and mortality (0.3% vs 0.1%; p < 0.0001) within 90 days of operation. After adjusting for sex, age, and body mass index, RYGB patients with MetS had an increased risk of 90-day serious complications compared to RYGB patients without MetS (odds ratio 1.43; 95% CI, 1.27 to 1.61; p < 0.0001). The 12-month remission rate of diabetes was least for gastric banding (28%) compared with the other procedures (RYGB 62%, sleeve gastrectomy 52%, BPD/DS 74%). Patients with MetS undergoing bariatric surgery showed dramatic improvement in diabetes 1-year after surgery; however, an adverse 90-day outcome was more common.
    Journal of the American College of Surgeons 02/2012; 214(4):550-6; discussion 556-7. · 4.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Laparoscopic adjustable gastric banding (LAGB) has become a standard restrictive procedure in the USA for the treatment of severe obesity (body mass index, BMI > 35 kg/m(2)). Mildly obese individuals (BMI < 35 kg/m(2)) are also at increased risk from obesity-related conditions. Recently, an FDA panel supported its use in this subgroup. We compared the perioperative outcomes of LAGB in mildly and severely obese. Thirty consecutive patients (mildly obese n=10; severely obese n=20) that underwent preoperative medical weight loss followed by LAGB procedures were prospectively evaluated. Outcome variables included: operative room (OR) time, intraoperative estimated blood loss (EBL), length of hospital (LOS), and intensive care unit (ICU) stay, reoperations, readmissions, 30-day morbidity and mortality. Demographic data was comparable between groups. BMI was significantly higher in the severely obese compared to mildly obese (44.0 ± 5 vs. 33.6 ± 1 kg/m(2)). OR time, EBL, LOS, and ICU admissions were similar between BMI groups. There were no reoperations or 30-day mortality in either group. Minor morbidity was only observed in the severely obese group. BMI correlated with OR time and EBL. In mildly obese, LAGB is as safe as in the severely obese with no perioperative morbidity. The perioperative outcomes and hospital resource utilization are comparable between BMI groups. Lower BMI is associated with lower operative times and blood loss.
    Obesity Surgery 02/2011; 21(4):421-5. · 3.10 Impact Factor